SCHEMBL4046393

SCHEMBL4046393

COC(c1ccccc1[N+](=O)[O-])C(C=O)C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
EED O75530 1/20 0.39
RBBP4 Q09028 1/20 0.39
SUZ12 Q15022 1/20 0.39
EZH2 Q15910 1/20 0.39
AEBP2 Q6ZN18 1/20 0.39
MET P08581 1/20 0.38
MMP13 P45452 5/20 0.38
MMP1 P03956 4/20 0.38
MMP3 P08254 3/20 0.38
MMP7 P09237 3/20 0.38
MMP9 P14780 3/20 0.38
MMP8 P22894 3/20 0.38
MMP2 P08253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL106237 0.78 ALDH1A1 (0.46) GPR119ALDH1A1LMNAMAPTEED
SCHEMBL23564637 0.76 KDM4E (0.44) GPR119ALDH1A1LMNAMAPTEED
SCHEMBL29151392 0.75 ALDH1A1 (0.43) GPR119ALDH1A1LMNAMAPTEED
SCHEMBL26912186 0.73 ALDH1A1 (0.43) GPR119ALDH1A1LMNAMAPTEED
SCHEMBL19268020 0.73 GPR119 (0.51) GPR119ALDH1A1LMNAMAPTMET
SCHEMBL2212752 0.72 GPR119 (0.47) GPR119ALDH1A1LMNAMAPTEED
SCHEMBL70414 0.71 KDM1A (0.53) GPR119ALDH1A1LMNAMAPTKDM4E
SCHEMBL15478923 0.71 GPR119 (0.46) GPR119ALDH1A1LMNAMAPTEED
SCHEMBL23826060 0.71 MMP13 (0.48) GPR119METMMP13MMP1MMP3
SCHEMBL23826062 0.71 MMP13 (0.48) GPR119METMMP13MMP1MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013213-A2 CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS Brystol-Myers Squibb Company (US) 2009-01-14 EP disclosed
WO-2007130860-A2 CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-11-15 WO disclosed
WO-2007130927-A2 CONDENSED TRICYCLIC COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-11-15 WO disclosed